More Galleries
Rebirth of America's dead factories Defunct factories around the country are in high demand as U.S. production once again revs up. More
7 hot businesses to start now It's hard to predict what businesses will take off, but these startup ideas have been drawing tons of interest from entrepreneurs and their customers on More
How will a minimum wage hike hit businesses? Thirteen states increased the minimum wage on Jan. 1, and President Obama supports raising the federal rate to $10.10. 4 small business owners weigh in on how an increase would affect them. More

Special Offer
22 of 36
Bringing TB diagnosis into the 21st century
Bringing TB diagnosis into the 21st century
John Agerholm, Martin Klint Hansen and Ninad Gujar
Team name: Immutell

School name: University of Aarhus, Aarhus School of Business, Denmark

Team members: Jesper Eugen Olsen, John Agerholm, Martin Klint Hansen, Morten Ruhwald, Ninad Gujar, Pernille Ravn

Concept: Tuberculosis remains a global epidemic. Most hospitals and healthcare facilities use the century-old Tuberculin Skin Test to diagnose the disease. Using its new Cell Mediated Immune Response technology, Immutell hopes to bring TB testing into the twenty-first century.

Immutell plans to first create a blood test for the IP-10 biomarker, a molecule created by TB antigens. Its method promises to detect the marker more accurately and less expensively than today's methods. If successful, the technique could eventually be used to diagnose other infectious diseases such as chlamydia, gonorrhea and malaria.Immutell's team members hail from the worlds of finance, management, engineering, and science, and bring a combined 50 years of experience to the project. The company hopes to launch its product first in the European market and then bring it to the United States.

Timeline: Assuming FDA approval in 2008, Immutell's product should be on the European market in 2009 and in the U.S. by mid-2010. - Jennifer Lawinski

NEXT: RFID tags for hospitals

Last updated May 02 2008: 11:51 AM ET
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer LIBOR Warning: Neither BBA Enterprises Limited, nor the BBA LIBOR Contributor Banks, nor Reuters, can be held liable for any irregularity or inaccuracy of BBA LIBOR. Disclaimer. Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.